Identifying clinicopathological risk factors for regional lymph node metastasis in Chinese patients with T1 breast cancer: a population-based study

ObjectivesTo analyze clinicopathological risk factors and regular pattern of regional lymph node metastasis (LNM) in Chinese patients with T1 breast cancer and the effect on overall survival (OS) and disease-free survival (DFS).Materials and methodsBetween 1999 and 2020, breast cancer patients meeti...

Full description

Bibliographic Details
Main Authors: Gang Liu, Zeyu Xing, Changyuan Guo, Qichen Dai, Han Cheng, Xiang Wang, Yu Tang, Yipeng Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-08-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1217869/full
_version_ 1797754557084729344
author Gang Liu
Zeyu Xing
Changyuan Guo
Qichen Dai
Han Cheng
Xiang Wang
Yu Tang
Yipeng Wang
author_facet Gang Liu
Zeyu Xing
Changyuan Guo
Qichen Dai
Han Cheng
Xiang Wang
Yu Tang
Yipeng Wang
author_sort Gang Liu
collection DOAJ
description ObjectivesTo analyze clinicopathological risk factors and regular pattern of regional lymph node metastasis (LNM) in Chinese patients with T1 breast cancer and the effect on overall survival (OS) and disease-free survival (DFS).Materials and methodsBetween 1999 and 2020, breast cancer patients meeting inclusion criteria of unilateral, no distant metastatic site, and T1 invasive ductal carcinoma were reviewed. Clinical pathology characteristics were retrieved from medical records. Survival analysis was performed using Kaplan−Meier methods and an adjusted Cox proportional hazards model.ResultsWe enrolled 11,407 eligible patients as a discovery cohort to explore risk factors for LNM and 3484 patients with stage T1N0 as a survival analysis cohort to identify the effect of those risk factors on OS and DFS. Compared with patients with N- status, patients with N+ status had a younger age, larger tumor size, higher Ki67 level, higher grade, higher HR+ and HER2+ percentages, and higher luminal B and HER2-positive subtype percentages. Logistic regression indicated that age was a protective factor and tumor size/higher grade/HR+ and HER2+ risk factors for LNM. Compared with limited LNM (N1) patients, extensive LNM (N2/3) patients had larger tumor sizes, higher Ki67 levels, higher grades, higher HR- and HER2+ percentages, and lower luminal A subtype percentages. Logistic regression indicated that HR+ was a protective factor and tumor size/higher grade/HER2+ risk factors for extensive LNM. Kaplan−Meier analysis indicated that grade was a predictor of both OS and DFS; HR was a predictor of OS but not DFS. Multivariate survival analysis using the Cox regression model demonstrated age and Ki67 level to be predictors of OS and grade and HER2 status of DFS in stage T1N0 patients.ConclusionIn T1 breast cancer patients, there were several differences between N- and N+ patients, limited LNM and extensive LNM patients. Besides, HR+ plays a dual role in regional LNM. In patients without LNM, age and Ki67 level are predictors of OS, and grade and HER2 are predictors of DFS.
first_indexed 2024-03-12T17:35:10Z
format Article
id doaj.art-f4b17d614cc84d2598429d6ce27e3152
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-03-12T17:35:10Z
publishDate 2023-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-f4b17d614cc84d2598429d6ce27e31522023-08-04T12:17:59ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2023-08-011310.3389/fonc.2023.12178691217869Identifying clinicopathological risk factors for regional lymph node metastasis in Chinese patients with T1 breast cancer: a population-based studyGang Liu0Zeyu Xing1Changyuan Guo2Qichen Dai3Han Cheng4Xiang Wang5Yu Tang6Yipeng Wang7Department of Breast Surgical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaDepartment of Breast Surgical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaDepartment of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaDepartment of Breast Surgical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaDepartment of Breast Surgical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaDepartment of Breast Surgical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaGCP center, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaDepartment of Breast Surgical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaObjectivesTo analyze clinicopathological risk factors and regular pattern of regional lymph node metastasis (LNM) in Chinese patients with T1 breast cancer and the effect on overall survival (OS) and disease-free survival (DFS).Materials and methodsBetween 1999 and 2020, breast cancer patients meeting inclusion criteria of unilateral, no distant metastatic site, and T1 invasive ductal carcinoma were reviewed. Clinical pathology characteristics were retrieved from medical records. Survival analysis was performed using Kaplan−Meier methods and an adjusted Cox proportional hazards model.ResultsWe enrolled 11,407 eligible patients as a discovery cohort to explore risk factors for LNM and 3484 patients with stage T1N0 as a survival analysis cohort to identify the effect of those risk factors on OS and DFS. Compared with patients with N- status, patients with N+ status had a younger age, larger tumor size, higher Ki67 level, higher grade, higher HR+ and HER2+ percentages, and higher luminal B and HER2-positive subtype percentages. Logistic regression indicated that age was a protective factor and tumor size/higher grade/HR+ and HER2+ risk factors for LNM. Compared with limited LNM (N1) patients, extensive LNM (N2/3) patients had larger tumor sizes, higher Ki67 levels, higher grades, higher HR- and HER2+ percentages, and lower luminal A subtype percentages. Logistic regression indicated that HR+ was a protective factor and tumor size/higher grade/HER2+ risk factors for extensive LNM. Kaplan−Meier analysis indicated that grade was a predictor of both OS and DFS; HR was a predictor of OS but not DFS. Multivariate survival analysis using the Cox regression model demonstrated age and Ki67 level to be predictors of OS and grade and HER2 status of DFS in stage T1N0 patients.ConclusionIn T1 breast cancer patients, there were several differences between N- and N+ patients, limited LNM and extensive LNM patients. Besides, HR+ plays a dual role in regional LNM. In patients without LNM, age and Ki67 level are predictors of OS, and grade and HER2 are predictors of DFS.https://www.frontiersin.org/articles/10.3389/fonc.2023.1217869/fullbreast cancersmall-sized tumor with extensive metastasishormone receptorclinical pathologylymph node metastasis
spellingShingle Gang Liu
Zeyu Xing
Changyuan Guo
Qichen Dai
Han Cheng
Xiang Wang
Yu Tang
Yipeng Wang
Identifying clinicopathological risk factors for regional lymph node metastasis in Chinese patients with T1 breast cancer: a population-based study
Frontiers in Oncology
breast cancer
small-sized tumor with extensive metastasis
hormone receptor
clinical pathology
lymph node metastasis
title Identifying clinicopathological risk factors for regional lymph node metastasis in Chinese patients with T1 breast cancer: a population-based study
title_full Identifying clinicopathological risk factors for regional lymph node metastasis in Chinese patients with T1 breast cancer: a population-based study
title_fullStr Identifying clinicopathological risk factors for regional lymph node metastasis in Chinese patients with T1 breast cancer: a population-based study
title_full_unstemmed Identifying clinicopathological risk factors for regional lymph node metastasis in Chinese patients with T1 breast cancer: a population-based study
title_short Identifying clinicopathological risk factors for regional lymph node metastasis in Chinese patients with T1 breast cancer: a population-based study
title_sort identifying clinicopathological risk factors for regional lymph node metastasis in chinese patients with t1 breast cancer a population based study
topic breast cancer
small-sized tumor with extensive metastasis
hormone receptor
clinical pathology
lymph node metastasis
url https://www.frontiersin.org/articles/10.3389/fonc.2023.1217869/full
work_keys_str_mv AT gangliu identifyingclinicopathologicalriskfactorsforregionallymphnodemetastasisinchinesepatientswitht1breastcancerapopulationbasedstudy
AT zeyuxing identifyingclinicopathologicalriskfactorsforregionallymphnodemetastasisinchinesepatientswitht1breastcancerapopulationbasedstudy
AT changyuanguo identifyingclinicopathologicalriskfactorsforregionallymphnodemetastasisinchinesepatientswitht1breastcancerapopulationbasedstudy
AT qichendai identifyingclinicopathologicalriskfactorsforregionallymphnodemetastasisinchinesepatientswitht1breastcancerapopulationbasedstudy
AT hancheng identifyingclinicopathologicalriskfactorsforregionallymphnodemetastasisinchinesepatientswitht1breastcancerapopulationbasedstudy
AT xiangwang identifyingclinicopathologicalriskfactorsforregionallymphnodemetastasisinchinesepatientswitht1breastcancerapopulationbasedstudy
AT yutang identifyingclinicopathologicalriskfactorsforregionallymphnodemetastasisinchinesepatientswitht1breastcancerapopulationbasedstudy
AT yipengwang identifyingclinicopathologicalriskfactorsforregionallymphnodemetastasisinchinesepatientswitht1breastcancerapopulationbasedstudy